Amphenol Corporation
81.34USD
-0.4200 (-0.51%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.72▲ | $0.63 | 11 | 0 |
| Next quarter | $0.74▲ | $0.65 | 11 | 0 |
| Current year | $2.66▲ | $2.41 | 13 | 0 |
| Next year | $3.25▲ | $2.84 | 13 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.6 | $0.68 | +0.08 (+13.2%) |
| 2026-03-31 | $0.47 | $0.53 | +0.06 (+12.0%) |
| 2025-12-31 | $0.47 | $0.49 | +0.01 (+3.1%) |
| 2025-09-30 | $0.4 | $0.47 | +0.07 (+16.5%) |
218 ratings from 29 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $175 $90 | Sep 9, 2026 |
| Barclays | Maintained | Overweight | $200 $100 | Sep 8, 2026 |
| UBS | Maintained | Buy | $185 $197 | Jul 30, 2026 |
| BNP Paribas | Maintained | Outperform | $200 $215 | Jul 30, 2026 |
| Citigroup | Maintained | Buy | $195 $210 | Jul 30, 2026 |
| Truist Securities | Maintained | Buy | $200 $215 | Jul 30, 2026 |
| TD Cowen | Maintained | Hold | $135 $175 | Jul 13, 2026 |
| Citigroup | Maintained | Buy | $180 $195 | Jul 13, 2026 |
| Barclays | Maintained | Overweight | $198 $200 | Jul 13, 2026 |
| UBS | Maintained | Buy | $178 $185 | Jul 9, 2026 |
| B of A Securities | Maintained | Buy | $180 $185 | Jul 9, 2026 |
| Barclays | Maintained | Overweight | $175 $180 | May 4, 2026 |
| JP Morgan | Maintained | Overweight | $190 $200 | Apr 30, 2026 |
| UBS | Maintained | Buy | $170 $178 | Apr 30, 2026 |
| Citigroup | Maintained | Buy | $170 $180 | Apr 30, 2026 |
| Evercore ISI Group | Maintained | Outperform | $165 $180 | Apr 30, 2026 |
| Truist Securities | Maintained | Buy | $182 $200 | Apr 30, 2026 |
| JP Morgan | Maintained | Overweight | $185 $190 | Apr 16, 2026 |
| UBS | Maintained | Buy | $174 $170 | Apr 14, 2026 |
| Jefferies | Upgraded from Hold | Buy | $150 $145 | Mar 31, 2026 |
| Barclays | Maintained | Overweight | $156 $175 | Jan 29, 2026 |
| Citigroup | Maintained | Buy | $175 $180 | Jan 29, 2026 |
| JP Morgan | Maintained | Overweight | $160 $185 | Jan 27, 2026 |
| UBS | Maintained | Buy | $152 $174 | Jan 14, 2026 |
| Citigroup | Maintained | Buy | $160 $175 | Jan 12, 2026 |
110 filings from 14 insiders · 9 buy / 5 sell over 6m
Officers and directors of APH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| LAMPO CRAIG AChief Financial Officer | Giftindirect | 54.5k | — | — | Aug 6, 2026 |
| SILVERMAN DAVID MOfficer | Exercise | 120.0k | $22.00 | $2.64M | Aug 5, 2026 |
| SILVERMAN DAVID MOfficer | Sell | 120.0k | $174.24 | $20.91M | Aug 5, 2026 |
| LAMPO CRAIG AChief Financial Officer | Exercise | 193.2k | $22.37 | $4.32M | Aug 4, 2026 |
| LAMPO CRAIG AChief Financial Officer | Sell | 193.2k | $167.31 | $32.32M | Aug 4, 2026 |
| D'AMICO LANCE EGeneral Counsel | Exercise | 100.0k | $22.37 | $2.25M | Aug 3, 2026 |
| D'AMICO LANCE EGeneral Counsel | Sell | 100.0k | $161.82 | $16.19M | Aug 3, 2026 |
| NORWITT RICHARD ADAMChief Executive Officer | Exercise | 686.1k | $22.37 | $15.35M | Jul 31, 2026 |
| NORWITT RICHARD ADAMChief Executive Officer | Sell | 686.1k | $161.57 | $110.99M | Jul 31, 2026 |
| FALCK DAVID PDirector | Grant | 1.6k | — | — | May 22, 2026 |
| ALTOBELLO NANCY A.Director | Grant | 1.6k | — | — | May 22, 2026 |
| LIVINGSTON ROBERT ADirector | Grant | 1.6k | — | — | May 22, 2026 |
| NORWITT RICHARD ADAMChief Executive Officer | Exercise | 130.8k | $22.37 | $2.93M | May 5, 2026 |
| NORWITT RICHARD ADAMChief Executive Officer | Sell | 130.8k | $142.04 | $18.71M | May 5, 2026 |
| D'AMICO LANCE EGeneral Counsel | Exercise | 50.0k | $22.55 | $1.13M | Feb 18, 2026 |
| LAMPO CRAIG AChief Financial Officer | Exercise | 100.0k | $22.00 | $2.20M | Feb 18, 2026 |
| LAMPO CRAIG AChief Financial Officer | Sell | 100.0k | $149.98 | $15.00M | Feb 18, 2026 |
| D'AMICO LANCE EGeneral Counsel | Sell | 50.0k | $149.88 | $7.49M | Feb 18, 2026 |
| NORWITT RICHARD ADAMChief Executive Officer | Exercise | 608.3k | $22.37 | $13.61M | Feb 12, 2026 |
| NORWITT RICHARD ADAMChief Executive Officer | Sell | 608.3k | $147.17 | $89.58M | Feb 12, 2026 |
No analyst notes on APH yet.
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 11 | 2 | 0 | 0 | Buy1.88 |
| 1 mo ago | 4 | 11 | 2 | 0 | 0 | Buy1.88 |
| 2 mo ago | 4 | 11 | 2 | 0 | 0 | Buy1.88 |
| 3 mo ago | 4 | 11 | 3 | 0 | 0 | Buy1.94 |